A pity we can't go back further. The data you posted suggests most of the top institutions churning Neuren have been losing alot of money doing this over the last 12months.I'd be curious whether UBS for example has previously booked profits on Neuren or whether their entire strategy has always been based on buy high sell low (which is what the data you posted suggests they were doing last 12 months).
A pity we can't go back further. The data you posted suggests...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.01 |
Change
-0.090(0.69%) |
Mkt cap ! $1.597B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.36 | $12.82 | $3.657M | 280.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 1414 | $13.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.02 | 212 | 12 |
View Market Depth
| Last trade - 15.42pm 16/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |